Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine
| Autor: | Rebecca J. Hornby, Leslie W.J. Baillie, Nicola C. Bailey, Lucy J. Wilkinson, E. Hugh Dyson, Andrew J. H. Simpson, Matthew G. Bell, Matthew J. Hepburn, Alfred J. Mateczun, Karen E. Brenneman |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male Dose-Response Relationship Immunologic Anthrax Vaccines medicine.disease_cause Neutralization Anthrax Immune system Antigen Neutralization Tests medicine Chemical Precipitation Humans Anthrax vaccines General Veterinary General Immunology and Microbiology biology Toxin business.industry Public Health Environmental and Occupational Health Middle Aged biology.organism_classification Antibodies Bacterial Bacillus anthracis Vaccination Infectious Diseases Immunology biology.protein Molecular Medicine Female Antibody business |
| Zdroj: | Vaccine. 25(32) |
| ISSN: | 0264-410X |
| Popis: | A pilot study compared the immune response of regular (0, 3, 6, 32 weeks) and extended (0, 10, 13, 32 weeks) schedules of the UK anthrax vaccine (anthrax vaccine precipitated, AVP). Concentrations of antibodies to protective antigen (PA) were higher (p0.05) among recipients of the extended (n=7) versus regular schedule (n=6) at week 32, and 2 weeks after the second and third vaccinations. Toxin neutralisation assay levels and anti-lethal factor antibodies followed patterns similar to anti-PA antibodies. Extending the interval between the first two AVP vaccinations may produce a stronger immune response, but persistence of this effect needs further study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect